Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis
Gespeichert in:
| Veröffentlicht in: | Clinical microbiology and infection 2023-06, Vol.29 (6), p.676-678 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 678 |
|---|---|
| container_issue | 6 |
| container_start_page | 676 |
| container_title | Clinical microbiology and infection |
| container_volume | 29 |
| creator | Luque-Paz, David Cuervo, Guillermo Miró, José M. Tattevin, Pierre |
| description | |
| doi_str_mv | 10.1016/j.cmi.2023.02.023 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04062205v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X23001131</els_id><sourcerecordid>2785196995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-68dcac970ccb3875a94011120ffde1331ddb25a3b7010818cf2eb3342a2fb38f3</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMo7u7oD_AiOeqhx3z0V_Agw7LrCgNeFL2FdKXiZOhOxqRnVPDHm2bWPXgQApUUTz2Qegl5wdmaM96-2a9h8mvBhFwzUY58RC553aqKtYo_Lneu-qqr5dcLcpXznrGCyPopuZBt36u2ri_J7y87Dzs6J29GaiP9gTQg2nd0M_kQDxg8-HH0ofqGYTZTeQV6wpSPmZp_CEC3aH7GgNTFRG_CjClCBCiwMwhm9JlisBFMsn72-Rl54syY8fl9XZHPtzefru-q7cf3H6432wpqyeaq7S0YUB0DGGTfNUbVjHMumHMWuZTc2kE0Rg4d46znPTiBQ_moMMKVASdX5PXZuzOjPiQ_mfRLR-P13Warlx6rWSsEa068sK_O7CHF70fMs558BhxHEzAesxZd33DVKtUUlJ9RSDHnhO7BzZleAtJ7XQLSS0CaCb1sf0Ve3uuPw4T2YeJvIgV4ewawLOTkMekMHgOg9Qlh1jb6_-j_AClDotM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2785196995</pqid></control><display><type>article</type><title>Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Luque-Paz, David ; Cuervo, Guillermo ; Miró, José M. ; Tattevin, Pierre</creator><creatorcontrib>Luque-Paz, David ; Cuervo, Guillermo ; Miró, José M. ; Tattevin, Pierre</creatorcontrib><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1016/j.cmi.2023.02.023</identifier><identifier>PMID: 36889644</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Ampicillin - therapeutic use ; Anti-Bacterial Agents - therapeutic use ; Ceftriaxone - therapeutic use ; Drug Therapy, Combination ; Endocarditis - drug therapy ; Endocarditis, Bacterial - drug therapy ; Endocarditis, Bacterial - microbiology ; Enterococcus faecalis ; Gentamicins - therapeutic use ; Gram-Positive Bacterial Infections - drug therapy ; Gram-Positive Bacterial Infections - microbiology ; Human health and pathology ; Humans ; Infectious diseases ; Life Sciences ; Microbiology and Parasitology ; Penicillins - therapeutic use</subject><ispartof>Clinical microbiology and infection, 2023-06, Vol.29 (6), p.676-678</ispartof><rights>2023 European Society of Clinical Microbiology and Infectious Diseases</rights><rights>Attribution - NonCommercial - NoDerivatives</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-68dcac970ccb3875a94011120ffde1331ddb25a3b7010818cf2eb3342a2fb38f3</citedby><cites>FETCH-LOGICAL-c430t-68dcac970ccb3875a94011120ffde1331ddb25a3b7010818cf2eb3342a2fb38f3</cites><orcidid>0000-0002-4523-675X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36889644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04062205$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Luque-Paz, David</creatorcontrib><creatorcontrib>Cuervo, Guillermo</creatorcontrib><creatorcontrib>Miró, José M.</creatorcontrib><creatorcontrib>Tattevin, Pierre</creatorcontrib><title>Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><subject>Ampicillin - therapeutic use</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Ceftriaxone - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Endocarditis - drug therapy</subject><subject>Endocarditis, Bacterial - drug therapy</subject><subject>Endocarditis, Bacterial - microbiology</subject><subject>Enterococcus faecalis</subject><subject>Gentamicins - therapeutic use</subject><subject>Gram-Positive Bacterial Infections - drug therapy</subject><subject>Gram-Positive Bacterial Infections - microbiology</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Life Sciences</subject><subject>Microbiology and Parasitology</subject><subject>Penicillins - therapeutic use</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2LFDEQhoMo7u7oD_AiOeqhx3z0V_Agw7LrCgNeFL2FdKXiZOhOxqRnVPDHm2bWPXgQApUUTz2Qegl5wdmaM96-2a9h8mvBhFwzUY58RC553aqKtYo_Lneu-qqr5dcLcpXznrGCyPopuZBt36u2ri_J7y87Dzs6J29GaiP9gTQg2nd0M_kQDxg8-HH0ofqGYTZTeQV6wpSPmZp_CEC3aH7GgNTFRG_CjClCBCiwMwhm9JlisBFMsn72-Rl54syY8fl9XZHPtzefru-q7cf3H6432wpqyeaq7S0YUB0DGGTfNUbVjHMumHMWuZTc2kE0Rg4d46znPTiBQ_moMMKVASdX5PXZuzOjPiQ_mfRLR-P13Warlx6rWSsEa068sK_O7CHF70fMs558BhxHEzAesxZd33DVKtUUlJ9RSDHnhO7BzZleAtJ7XQLSS0CaCb1sf0Ve3uuPw4T2YeJvIgV4ewawLOTkMekMHgOg9Qlh1jb6_-j_AClDotM</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Luque-Paz, David</creator><creator>Cuervo, Guillermo</creator><creator>Miró, José M.</creator><creator>Tattevin, Pierre</creator><general>Elsevier Ltd</general><general>Elsevier for the European Society of Clinical Microbiology and Infectious Diseases</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-4523-675X</orcidid></search><sort><creationdate>20230601</creationdate><title>Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis</title><author>Luque-Paz, David ; Cuervo, Guillermo ; Miró, José M. ; Tattevin, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-68dcac970ccb3875a94011120ffde1331ddb25a3b7010818cf2eb3342a2fb38f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Ampicillin - therapeutic use</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Ceftriaxone - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Endocarditis - drug therapy</topic><topic>Endocarditis, Bacterial - drug therapy</topic><topic>Endocarditis, Bacterial - microbiology</topic><topic>Enterococcus faecalis</topic><topic>Gentamicins - therapeutic use</topic><topic>Gram-Positive Bacterial Infections - drug therapy</topic><topic>Gram-Positive Bacterial Infections - microbiology</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Life Sciences</topic><topic>Microbiology and Parasitology</topic><topic>Penicillins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luque-Paz, David</creatorcontrib><creatorcontrib>Cuervo, Guillermo</creatorcontrib><creatorcontrib>Miró, José M.</creatorcontrib><creatorcontrib>Tattevin, Pierre</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luque-Paz, David</au><au>Cuervo, Guillermo</au><au>Miró, José M.</au><au>Tattevin, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>29</volume><issue>6</issue><spage>676</spage><epage>678</epage><pages>676-678</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>36889644</pmid><doi>10.1016/j.cmi.2023.02.023</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-4523-675X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1198-743X |
| ispartof | Clinical microbiology and infection, 2023-06, Vol.29 (6), p.676-678 |
| issn | 1198-743X 1469-0691 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_04062205v1 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Ampicillin - therapeutic use Anti-Bacterial Agents - therapeutic use Ceftriaxone - therapeutic use Drug Therapy, Combination Endocarditis - drug therapy Endocarditis, Bacterial - drug therapy Endocarditis, Bacterial - microbiology Enterococcus faecalis Gentamicins - therapeutic use Gram-Positive Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - microbiology Human health and pathology Humans Infectious diseases Life Sciences Microbiology and Parasitology Penicillins - therapeutic use |
| title | Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T10%3A15%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Which%20trial%20do%20we%20need?%20Aminopenicillin-gentamicin%20versus%20aminopenicillin-ceftriaxone%20for%20Enterococcus%20faecalis%20endocarditis&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Luque-Paz,%20David&rft.date=2023-06-01&rft.volume=29&rft.issue=6&rft.spage=676&rft.epage=678&rft.pages=676-678&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1016/j.cmi.2023.02.023&rft_dat=%3Cproquest_hal_p%3E2785196995%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2785196995&rft_id=info:pmid/36889644&rft_els_id=S1198743X23001131&rfr_iscdi=true |